Abstract

Lethal mutagenesis is a promising new antiviral therapy that kills a virus by raising its mutation rate. One potential shortcoming of lethal mutagenesis is that viruses may resist the treatment by evolving genomes with increased robustness to mutations. Here, we investigate to what extent mutational robustness can inhibit extinction by lethal mutagenesis in viruses, using both simple toy models and more biophysically realistic models based on RNA secondary-structure folding. We show that although the evolution of greater robustness may be promoted by increasing the mutation rate of a viral population, such evolution is unlikely to greatly increase the mutation rate required for certain extinction. Using an analytic multi-type branching process model, we investigate whether the evolution of robustness can be relevant on the time scales on which extinction takes place. We find that the evolution of robustness matters only when initial viral population sizes are small and deleterious mutation rates are only slightly above the level at which extinction can occur. The stochastic calculations are in good agreement with simulations of self-replicating RNA sequences that have to fold into a specific secondary structure to reproduce. We conclude that the evolution of mutational robustness is in most cases unlikely to prevent the extinction of viruses by lethal mutagenesis.

Highlights

  • Lethal mutagenesis is a proposed therapy for patients with viral infections

  • We ask, how will elevating the mutation rate increase the rate at which populations move to areas of a neutral network with higher equilibrium neutrality? We find with a semi-deterministic model that the time it takes for a population undergoing mutagenesis to find the optimal area of the

  • We have studied how the evolution of mutational robustness affects lethal mutagenesis

Read more

Summary

Introduction

Lethal mutagenesis is a proposed therapy for patients with viral infections. We analyze the risk that lethal mutagenesis therapy will fail as a result of the virus population evolving mutational robustness. Several recent works have started to develop a theoretical framework to describe lethal mutagenesis [18,19,20,21,22]. Theoretical work has led to the prediction that lethal mutagenesis could be a viable treatment for bacterial infections [20,22]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call